Brief: IGC Completes The Final Cohort Of Its Phase 1 Clinical Trial On Alzheimer's Patients

IGC Pharma

23/06/2021 23:53

June 23 (Reuters) - India Globalization Capital Inc  IGC.A :
    * IGC COMPLETES THE FINAL COHORT OF ITS PHASE 1 CLINICAL
TRIAL ON
ALZHEIME'S PATIENTS
    * DATA AND SAFETY MONITORING COMMITTEE FOR IGC'S CLINICAL
TRIAL
WILL REVIEW DATA FROM COHORT 3, IGC WILL REPORT FINDINGS FROM
ALL 3 COHORTS TO FDA

Source text for Eikon:  ID:nBwZLtxRa 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))